Benefits and risks of third-generation oral contraceptives (Q33778866)

29 July 2017

1 reference

title

Benefits and risks of third-generation oral contraceptives (English)

1 reference

29 July 2017

E S Leblanc

1

1 reference

29 July 2017

A Laws

series ordinal

2

1 reference

29 July 2017

publication date

1 October 1999

1 reference

Journal of General Internal Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

14

1 reference

29 July 2017

issue

10

1 reference

29 July 2017

page(s)

625-632

1 reference

Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Myocardial infarction in users of low-dose oral contraceptives.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Comments on desogestrel and gestoden (3rd generation progestogens) and the incidence of thromboembolism

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Clinical evidence of the minimal androgenic activity of norgestimate

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Supportive European data on a new oral contraceptive containing norgestimate.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

The metabolic impact of oral contraceptives

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Oral contraceptives and death from myocardial infarction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Oral contraceptive use in older women and fatal myocardial infarction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Association Between Oral Contraceptives and Myocardial Infarction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Oral-contraceptive use in relation to myocardial infarction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women

4 July 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

Stroke in users of low-dose oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

Use of low-dose oral contraceptives and stroke in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

Third-generation oral contraceptives and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

Lowered risk of dying of heart attack with third generation pill may offset risk of dying of thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

OC practice guidelines: minimizing side effects.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496751

Third-generation oral contraceptives and venous thrombosis

30 October 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

Risk of acute myocardial infarction and low-dose combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.08108.X

Oral contraceptives and thrombotic disease: risk of venous thromboembolism

21 January 2018

1 reference

12 December 2020

Thromboembolic stroke in young women. A European case-control study on oral contraceptives. Transnational Research Group on Oral Contraceptives and the Health of Young Women

1 reference

12 December 2020

Oral contraceptives and venous thromboembolism. A case-control study

1 reference

12 December 2020

Oral contraceptive use in relation to nonfatal myocardial infarction

1 reference

12 December 2020

Risk of Myocardial Infarction in Relation to Current and Discontinued Use of Oral Contraceptives

1 reference

12 December 2020

Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination

1 reference

12 December 2020

Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives

1 reference

12 December 2020

Myocardial infarction and cigarette smoking in women younger than 50 years of age

1 reference

12 December 2020

The varying effects of progestins on lipid levels and cardiovascular disease

1 reference

12 December 2020

Gestoden, an innovative progestogen

1 reference

12 December 2020

A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases

1 reference

12 December 2020

Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive

1 reference

12 December 2020

Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial

1 reference

12 December 2020

Oral contraceptive use and the risk of myocardial infarction

1 reference

12 December 2020

Efficacy and clinical profile of a new oral contraceptive containing norgestimate. U.S. clinical trials

1 reference

12 December 2020

Clinical experience with a new norgestimate-containing oral contraceptive

1 reference

12 December 2020

Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study

1 reference

12 December 2020

The efficacy and tolerability of norgestimate/ethinyl estradiol (250 μg of norgestimate/35 μg of ethinyl estradiol): Results of an open, multicenter study of 59,701 women

1 reference

12 December 2020

A multicenter efficacy and safety study of an oral contraceptive containing 150 micrograms desogestrel and 30 micrograms ethinyl estradiol

1 reference

12 December 2020

A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids

1 reference

12 December 2020

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

12 December 2020

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

12 December 2020

Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

12 December 2020

Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

12 December 2020

Selective prescribing of third generation oral contraceptives (OCs)

1 reference

12 December 2020

The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study

1 reference

12 December 2020

Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives

1 reference

12 December 2020

Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

12 December 2020

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives

1 reference

12 December 2020

10.1046/J.1525-1497.1999.08108.X

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference